What is US8829195 (asciminib) on Google Patents?
US8829195 is a published US patent in the asciminib (ABL) technology area that you can find on Google Patents by searching the patent number directly. [1]
On Google Patents, the record typically shows bibliographic data (assignee, inventor(s), publication/grant dates), plus the full claim set and document images. [1]
What is asciminib, and how does this patent fit?
Asciminib is an inhibitor developed for targeting ABL kinase activity (often discussed in the context of CML/Philadelphia chromosome–positive disease). The US patent number you referenced (US8829195) is a specific IP document within that broader technology space, and its exact role depends on what the patent claims cover (for example, the specific compounds, binding approach, or related methods). [1]
How do I verify the exact assignee and claim focus for US8829195?
On the Google Patents page for US8829195, check:
- Assignee/inventor fields (to confirm who holds or prosecuted the patent)
- The claims (to see what scope the patent actually covers)
- The “Related documents” section (to connect it to earlier applications or family members) [1]
Is there any patent-expiry or exclusivity info I should look up for US8829195?
Google Patents can show filing dates and the patent term framework, but actual expiry can depend on factors such as continuation/divisional filings, adjustments, and any applicable extensions. For practical, market-focused patent tracking, DrugPatentWatch is often used to map patent families and relevant listings tied to a drug product. [2]
If you want, share the assignee name from the Google Patents page and/or the priority year you see there, and I can help interpret how that might affect timing.
Where can I cross-check this patent with a market-focused database?
DrugPatentWatch.com is one option to cross-check patent listings related to asciminib and to see how patents are mapped to drug products. It can help when you need the “patent thicket” view rather than just a single document record. [2]
- DrugPatentWatch (asciminib-related patent tracking): https://www.drugpatentwatch.com/
Sources below include both Google Patents and DrugPatentWatch, where relevant.
---
Sources
[1] https://patents.google.com/patent/US8829195
[2] https://www.drugpatentwatch.com/